The spectrum of a compound or mixture of compounds may be mathematically differentiated to produce derivative spectra. Although this concept has been known for many years (1) and its theory and potential usage have been well reviewed (2) (3) (4) , and despite the availability of this technique on many modern recording spectrophotometers, it has found little application in clinical chemistry. Odd-numbered derivatives are of most use in determining the exact points of absorbance maxima of the original or zero-order spectrum and hence the qualitative properties of the substance under investigation; even-numbered derivatives are helpful in quantitative determinations (2) . The latter prove particularly useful when the properties of the zero-order spectrum are changed owing to interferents such as baseline shift, change in baseline slope, the presence of other compounds with similar optical properties, or the presence of inert material such as air bubbles, insoluble material, or colloidal particles. Variations between samples because of baseline differences, refractive index, or reagent purity may also be compensated for. Despite these potential advantages, the reported applications in clinical chemistry are few, but include the measurement of porphyrins
, and benzodiazepunes (8). 
Materials and Methods

Preparation of calibrants.
Two 10-mL samples of heparmnized blood from a healthy nonsmoker were treated in separate 100-mL flasks (Jencons Scientific Ltd., Leighton sample by gassing with 100% nitrogen (BOC Ltd., London, SW19 3UF, U.K.) for 5 mm with gentle agitation. These two preparations were used as 0 and 100% carboxyhemoglobin standards, from which intermediary standards were also prepared, in accordance with the procedure of Tietz and Fiereck (9) .
Determination of carboxyhemoglobin.
Reducing reagent is prepared immediately before use (because it is only stable for a few hours), as follows. Mix 1.6 mL of ammonia solution (relative density 0.88) and 0.25 g of sodium dithionite (both from B.D.H. Chemicals Ltd., Poole, BH12 4NN, U.K.) and dilute to 100 mL with water. Add 10 mL of the reducing reagent to 10 1&L of fresh whole blood coflected into an EDTA-containing blood tube, mix thoroughly by inversion, and allow to stand for 5 miii. Measure the second-derivative spectrum between 390 and 450 nm (we used a Unicam P.U. 8800 scanning spectrophotometer;
Pye Unicam Ltd., Cambridge, CB1 2PX, U.K.). Calibrants are similarly treated.
Results
Oxyhemoglobin is reduced by treatment with dithionite, which simplifies the situation because only the spectra of reduced hemoglobin and carboxyhemoglobin then need be considered. Figure  1 shows the zero-order spectra of (a) reduced hemoglobin with absorbance peaks at 430 and 555 am; (b) carboxyhemoglobun with peaks at 418, 540, and 570 mu; and (c) a mixture of reduced and carboxyhemoglobin with one broad peak, having a maximum between 418 and 430 am, its exact location depending upon the relative proportion of reduced and carboxyhemoglobin. Optimum conditionsare achieved only by trial and error and may vary from one instrument to another. For the estimation of carboxyhemoglobin with the P.U. 8800 we found aband width of 0.2 nm and a scan speed of 1 nm/s to be satisfactory.
To determine the precision of the method, we made 15 replicate analyses of 20 and 50% carboxyhemoglobmn standards within one day. The respective CVs were 2.9 and 3.3%. For 50 selected patients' samples, 25 smokers and 25 nonsmokers, results by this method were compared with those by the method of Tietz and Fiereck (9) , and correlated well when the carboxyhemoglobin content exceeded 5%. Below 5% the Tietz and Fiereck method is too insensitive to produce a good correlation; 15 samples gave results of less than zero. On the basis of the data from nonsmokers, we established an upper limit of 2.0% for the reference interval (Figure 4 ). there is also a need for more sensitive measurements of carboxyhemoglobin concentrations below 10%. Derivative spectral analysis fulfils these criteria. The initial reduction is fast, and the spectral analysis is straightforward and takes only a few minutes to perform. The only problem is the instability of the reducing agent, which must be freshly prepared.
Dscusslon
We suggest that for emergency use pre-weighed portions of sodium dithionite be kept at hand, which then would require only the addition of ammonia solution and water for solubilization.
The sensitivity of the method is demonstrated by the discrimination of smokers and nonsmokers in Figure 4 .
Calibration and the preparation of standards is laborious, but these need not be done with every investigation.
Repeated checks on the calibration curve show it is consistent for a given instrument. Because a ratio is being measured, the procedure is not operator dependent beyond the actual amplitude measurements of the spectrum. This is fortunate, The standards are not stable and therefore must be prepared immediately before use. The standard gassed with carbon monoxide is assumed to be converted to 100%
carboxyhemoglobin, and although this has not been proven, the reproducible nature of the calibration curve has demonstrated consistency. However, this preparation must subsequently be treated sufficiently thoroughly with nitrogen to remove all dissolved carbon monoxide. We have not rigorously checked the effect of other hemoglobins but we do not believe that they will present a problem. Methemoglobin would be reduced to reduced hemoglobin and would therefore rightly contribute to the noncarboxylated fraction. Sulfhemoglobin would be unaffected but does not have an absorbance peak within the 390-450 urn region.
Although this method could be applied to samples collected post-mortem, it has not been used in this context; it would therefore be important to establish the absence of any interfering substances that are not present in living subjects.
tested, and the cost to society of false-positive and falsenegative results (4) . Once the medical priorities have been set, then a more objective answer is possible as to medical needs, and the suitability of an instrument can be determined largely from laboratory experiments.
Here we follow the goal setting described by Harris (2) for testing a population to identify individuals with a biochemical abnormality. This appears to be the most prevalent use of the Du Pont aca IV, hence our choice of this model. Our choice is arbitrary; as described by Harris, goal setting could equally well be based on the detection of life-threatening biochemical abnormalities or on the determination of within-person trends with time of an analyte.
Materials and Methods
Statistical Model
The model for goal setting assumes a gaussian distribution of results for both the well and the sick, and an overlap of the results such that both clinical sensitivity and specificity are always less than one (5). Overlapping populations are the usual case; however, the distributions are usually not gaussian (6) . Nevertheless, in this context it is a useful device to use in making an estimate of medical needs. We assumed that the optimum decision point between well and sick is at the midpoint of the overlapping values, that an increased value is abnormal, and that 2.3% of the well have values exceeding the decision point, and 2.3% of the sick have values below the decision point. In this model, the
